voglibose inn usan trade name voglib marketed mascot health series alphaglucosidase inhibitor used lowering postprandial blood glucose levels people diabetes voglibose delays absorption glucose thereby reducing risk macrovascular complications voglibose research product takeda pharmaceutical company japans largest pharmaceutical company vogilbose discovered first launched japan trade name basen improve postprandial hyperglycemia diabetes postprandial hyperglycemia pphg primarily due first phase insulin secretion alpha glucosidase inhibitors delay glucose absorption intestine level thereby prevent sudden surge glucose three major drugs belong class acarbose miglitol voglibose newest cochrane systematic review assessed effect alphaglucosidase inhibitors people impaired glucose tolerance impaired fasting blood glucose elevated glycated hemoglobin found conclusive evidence voglibose compared diet exercise placebo reduced incidence diabetes mellitus type improved allcause mortality reduced increased risk cardiovascular mortality serious nonserious adverse events nonfatal stroke congestive heart failure nonfatal myocardial httpsenwikipediaorgwikivoglibose